GE HealthCare is trading 10.1% up at $70.61 after reporting a second-quarter 2026 earnings beat and record organic orders growth.
- The company posted $5.3 billion in revenue and $1.24 diluted EPS, while reaffirming its full-year 2026 financial outlook.
- Results were highlighted by record organic orders growth of 11.1% and a $23.9 billion backlog, signaling strong demand visibility with a 1.15 book-to-bill ratio.